Category: Top Story

Rekor Systems (NASDAQ:REKR) shares surged 23% on Tuesday after the company announced it had secured its largest statewide contract to date with the Georgia Department of Transportation (GDOT) — a deal valued at a minimum of $50 million over its full term. The multi-year agreement, which may be extended up to seven years at GDOT’s…

James Hardie Industries plc (NYSE:JHX) shares surged 10% on Tuesday after the building materials manufacturer posted preliminary second-quarter results that came in well above Wall Street expectations, thanks to resilient performance in its Siding & Trim division. The company said it expects net sales between $1.29 billion and $1.30 billion for the quarter — far…

Jade Biosciences (NASDAQ:JBIO) shares surged 20% on Tuesday after the clinical-stage biotech company unveiled JADE201, a new potentially best-in-class therapy for autoimmune diseases, alongside news of a $135 million private investment in public equity (PIPE) financing round. JADE201 is an investigational half-life extended, afucosylated monoclonal antibody designed to target the B-cell activating factor receptor (BAFF-R).…

Lexeo Therapeutics (NASDAQ:LXEO) shares skyrocketed 25% on Tuesday after the clinical-stage genetic medicine company announced significant progress in its discussions with the U.S. Food and Drug Administration (FDA) regarding an accelerated approval pathway for LX2006, its investigational treatment for Friedreich ataxia cardiomyopathy. According to Lexeo, the FDA is open to allowing pooled data from the…

McCormick & Company (NYSE:MKC) shares edged up 1% in premarket trading on Monday after the global spice and flavoring leader reported third-quarter results that topped Wall Street forecasts, marking its fifth straight quarter of volume-driven growth despite ongoing cost headwinds. For the quarter ended August 31, the company posted adjusted earnings per share of $0.85,…

James Hardie Industries (NYSE:JHX) shares jumped 14% in premarket trading on Tuesday after the building materials giant reported preliminary second-quarter sales between $1.29 billion and $1.3 billion, well above analyst estimates of $1.17 billion. The company also posted earnings per share of $0.26, easily surpassing the consensus forecast of $0.15. The strong results were fueled…

IBM (NYSE:IBM) shares surged nearly 7% in pre-market trading on Tuesday after the tech giant unveiled a strategic collaboration with Anthropic to integrate its Claude AI model into IBM’s software ecosystem. The partnership will kick off with the integration of Claude into IBM’s new AI-first Integrated Development Environment (IDE), which is currently in private preview…

AppLovin (NASDAQ:APP) shares continued to slide on Tuesday, falling 3.2% in premarket trading following a steep 14% drop on Monday, after reports emerged that the U.S. Securities and Exchange Commission (SEC) has opened an investigation into the company’s data-collection practices. According to Bloomberg, which cited sources familiar with the matter, the SEC is examining whether…

Shares of Intercontinental Exchange (NYSE:ICE) — the parent company of the New York Stock Exchange (NYSE) — rose more than 4% in pre-market trading on Tuesday, after a report from The Wall Street Journal suggested the firm is nearing a $2 billion investment in Polymarket, a cryptocurrency-based prediction platform. According to the report, Intercontinental Exchange…

Shares of Valneva SE (NASDAQ:VALN) dropped 6.4% on Tuesday after the French vaccine developer revised its 2025 financial outlook downward following the U.S. FDA’s suspension of the product license for its IXCHIQ vaccine. The company now anticipates product sales of €155–170 million, down from its earlier projection of €170–180 million. Total revenue guidance has been…